NCI IMAT — Innovative Molecular Analysis Technologies
Helps NCI IMAT Innovative Molecular Analysis Technologies for Early-stage development of novel cancer research technologies.
About
NCI IMAT is a long-running program in the Center for Strategic Scientific Initiatives that supports early-stage development of innovative molecular and cellular analysis technologies for cancer research. Established in 1998, it now runs as an R61/R33 program with annual solicitations.
The R61 phase supports proof-of-concept work with no preliminary data required and up to $150,000 in direct costs…
AIBiotechMedtech
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.